Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
JAMES W MCCOLLUM Insider Profile
4 Followers
JAMES W MCCOLLUM, Director at LENZ Therapeutics, holds 620.60K shares in LENZ Therapeutics (Ticker: LENZ). Most recently, JAMES W MCCOLLUM Bought $31,332 shares of LENZ Therapeutics on May 14, 2024 for an estimated value of 501.00K.
JAMES W MCCOLLUM has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of JAMES W MCCOLLUM's holdings
Insider Roles
Director
Roles that JAMES W MCCOLLUM holds in companies
Most Profitable Insider Trade
The most profitable trade made by JAMES W MCCOLLUM
JAMES W MCCOLLUM's Trading History
List of latest transactions for each holding click on a transaction to see JAMES W MCCOLLUM's performance on stock
You May Also Like
JAMES W MCCOLLUM insider profile FAQ
What is the percentage of profitable transactions made by JAMES W MCCOLLUM?
The percentage of profitable transactions made by JAMES W MCCOLLUM is ―.
What is the average return per transaction made by JAMES W MCCOLLUM?
The average return per transaction made by JAMES W MCCOLLUM is ―.
What stocks does JAMES W MCCOLLUM hold?
JAMES W MCCOLLUM holds: LENZ stocks.
What was JAMES W MCCOLLUM’s latest transaction?
JAMES W MCCOLLUM latest transaction was an Informative Buy of $501.00K.
What was JAMES W MCCOLLUM's most profitable transaction?
JAMES W MCCOLLUM’s most profitable transaction was an Informative Buy of LENZ stock on May 14, 2024. The return on the trade was 107.50%.
What is JAMES W MCCOLLUM's role in LENZ Therapeutics?
JAMES W MCCOLLUM's role in LENZ Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.